Ensign Group (NASDAQ: ENSG) lifts stock buyback authorization to $100M
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
The Ensign Group, Inc. announced that its board approved a $60 million increase to its previously authorized $40 million stock repurchase program, raising total buyback capacity to $100 million. Repurchases may occur in open‑market and privately negotiated transactions, including under Rule 10b‑18 and Rule 10b5‑1 plans.
The program is discretionary, with no obligation to repurchase a specific amount, and can be modified, suspended or discontinued at any time. Management highlights strong financial performance and a focus on disciplined capital allocation as it prepares to commence repurchases under the expanded authorization in the near term.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 8.01, 9.01
2 items
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Repurchase increase: $60 million
Prior authorization: $40 million
Total buyback capacity: $100 million
+2 more
5 metrics
Repurchase increase
$60 million
Newly approved expansion of stock repurchase authorization
Prior authorization
$40 million
Previously approved stock repurchase program size
Total buyback capacity
$100 million
Aggregate authorized stock repurchase capacity after increase
Healthcare facilities
396 facilities
Number of facilities where Ensign subsidiaries provide services
Press release date
June 15, 2026
Date of press release announcing increased authorization
Key Terms
stock repurchase program, Rule 10b-18, Rule 10b5-1, forward-looking statements, +2 more
6 terms
stock repurchase program financial
"approved a $60 million increase to the Company’s previously approved $40 million stock repurchase program"
A stock repurchase program is when a company buys back its own shares from the market. This can make each remaining share more valuable and shows that the company believes its stock is a good investment. It’s like a business treating its shares like a limited resource, hoping to boost confidence and share prices.
Rule 10b-18 regulatory
"including pursuant to Rule 10b-18 and Rule 10b5‑1 plans"
Rule 10b-18 is a regulation that sets strict rules for how a company's executives and employees can buy back their own company's stock from the market. It helps ensure that these buybacks happen in a fair and transparent way, reducing the chance of market manipulation. This is important for investors because it offers protection against unfair practices and promotes confidence in the integrity of the stock market.
Rule 10b5-1 regulatory
"including pursuant to Rule 10b-18 and Rule 10b5‑1 plans"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
forward-looking statements regulatory
"This press release contains “forward-looking” statements within the meaning of Section 27A"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
Private Securities Litigation Reform Act of 1995 regulatory
"as defined in the U.S. Private Securities Litigation Reform Act of 1995"
disciplined capital allocation financial
"our ongoing commitment to disciplined capital allocation"
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 12, 2026
The Ensign Group, Inc .
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||||||||||||||
| (Address of principal executive offices) | (Zip Code) | |||||||||||||||||||
Registrant's telephone number, including area code: (949 ) 487-9500
Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | ||||||||
| Securities registered pursuant to Section 12(b) of the Act: | ||||||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01. Other Events.
On June 12, 2026, the Board of Directors of The Ensign Group, Inc. (the “Company”) approved a $60 million increase to the Company’s previously authorized $40 million stock repurchase program, bringing the Company’s total authorized repurchase capacity to $100 million.
The Company may repurchase shares from time to time in open market or privately negotiated transactions, including pursuant to Rule 10b-18 and Rule 10b5‑1 plans, or by other means in accordance with applicable securities laws. The program does not obligate the Company to acquire any specific number of shares, and may be modified, suspended, or discontinued at any time. Repurchases will depend on the Company’s business strategy, market conditions, liquidity requirements, contractual restrictions, and other factors.
A copy of the Company's press release announcing the share repurchase program is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit No. | Description | |||||||
99.1 | Press Release of the Company dated June 15, 2026 | |||||||
| 104 | Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document. | |||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| THE ENSIGN GROUP, INC. | ||||||||
Dated: June 15, 2026 | /s/ Suzanne D. Snapper | |||||||
| Suzanne D. Snapper | ||||||||
| Chief Financial Officer, Executive Vice President and Director (principal financial officer and principal accounting officer) | ||||||||
The Ensign Group, Inc. Announces Increased Stock Repurchase Authorization
SAN JUAN CAPISTRANO, Calif., June 15, 2026 – The Ensign Group, Inc. (Nasdaq: ENSG) (“Ensign” or the “Company”), the parent company of the EnsignTM group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that its Board of Directors has approved a $60 million increase to the Company’s previously approved $40 million stock repurchase program, bringing the Company’s total authorized repurchase capacity to $100 million. Repurchases under the expanded program are expected to commence in the near term.
"Ensign’s strong financial performance reflects the benefits of our proven business model built on clinical excellence, local leadership and a culture focused on providing compassionate, high-quality care for our residents," said Barry Port, Ensign's Chairman and Chief Executive Officer. “We believe that foundation, together with the continued trust and support from our communities and the strong demand we see across our markets, positions us well for continued long‑term success. The increased stock repurchase authorization underscores our confidence in the strength, integrity and upside potential of our company, as well as our ongoing commitment to disciplined capital allocation.”
Under the stock repurchase program, the Company is authorized to repurchase its issued and outstanding common shares from time to time in open-market and privately negotiated transactions and block trades in accordance with federal securities laws, including Rule 10b-18 and Rule 10b5-1. The timing and actual number of shares repurchased by the Company under this program will depend on a variety of factors, including price, trading volume, general market conditions, and other corporate considerations. The Company has no obligation to repurchase any particular dollar amount or number of shares under the stock repurchase program, and the program may be suspended, discontinued or modified at any time, without prior notice and subject to legal and regulatory requirements.
Cautionary Note Regarding Forward-Looking Statements
This press release contains “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These statements are based on management’s current expectations, assumptions and beliefs about its business, financial performance, operating results, the industry in which it operates and other future events. Forward-looking statements can often be identified by words such as "anticipates," "expects," "intends," "plans," "predicts," "believes," "seeks," "estimates," "may," "will," "should," "would," "could," "potential," "continue," "ongoing," similar expressions, and variations or negatives of these words. These forward-looking statements include, but are not limited to, statements regarding the amount, timing and execution of the stock repurchase program, growth prospects, and future operating and financial performance. They are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to materially and adversely differ from those expressed in any forward-looking statement.
These risks and uncertainties relate to the Company’s business, its industry and its common stock and include: reduced prices and reimbursement rates for its services; its ability to acquire, develop, manage or improve operations, its ability to manage its increasing borrowing costs as it incurs additional indebtedness to fund the acquisition and development of operations; its ability to access capital on a cost-effective basis to continue to successfully implement its growth strategy; its operating margins and profitability could suffer if it is unable to grow and manage effectively its increasing number of operations; competition from other companies in the acquisition, development and operation of facilities; its ability to defend claims and lawsuits, including professional liability claims alleging that our services resulted in personal injury, and other regulatory-related claims; and the application of existing or proposed government regulations, or the adoption of new laws and regulations, that could limit its business operations, require it to incur significant expenditures or limit its ability to relocate its operations if necessary. Additionally, our business and operations continue to be impacted by the unprecedented nature of the changes in the regulations and environment, as such, we are unable to predict the full extent and duration of the financial impact of these changes on our business, financial condition and results of operations. Therefore, our actual results could differ materially and adversely from those expressed in any forward-looking statements as a result of various factors. Readers should not place undue reliance on any forward-looking statements and are encouraged to review the Company’s periodic filings with the Securities and Exchange Commission, including its Form 10-Q and 10-K, for a more complete discussion of the risks and other factors that could affect Ensign’s business, prospects and any forward-looking statements. Except as required by the federal securities laws, Ensign does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changing circumstances or any other reason after the date of this press release.
About Ensign™
The Ensign Group, Inc.'s independent operating subsidiaries provide a broad spectrum of skilled nursing and senior living services, physical, occupational and speech therapies and other rehabilitative and healthcare services at 396 healthcare facilities in Alabama, Alaska, Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, Oregon, South Carolina, Tennessee, Texas, Utah, Washington and Wisconsin. More information about Ensign is available at http://www.ensigngroup.net.
Contact Information
Investor/Media Relations, The Ensign Group, Inc., (949) 487-9500, ir@ensignservices.net.
SOURCE: The Ensign Group, Inc.
FAQ
What stock repurchase change did The Ensign Group (ENSG) approve?
The Ensign Group’s board approved a $60 million increase to its stock repurchase program, lifting total authorized buybacks from $40 million to $100 million for future share repurchases.
What is The Ensign Group’s total stock buyback authorization now?
The Ensign Group’s total authorized stock repurchase capacity is now $100 million, up from a prior $40 million authorization, following a newly approved $60 million increase to the program.
How will The Ensign Group (ENSG) execute its stock repurchases?
The Ensign Group may repurchase shares in open‑market and privately negotiated transactions and block trades, in accordance with federal securities laws, including Rule 10b‑18 and Rule 10b5‑1 trading plans.
How large is The Ensign Group’s operating footprint mentioned in this update?
The Ensign Group’s independent operating subsidiaries provide services at 396 healthcare facilities across multiple U.S. states, including California, Texas, Arizona, Utah, Washington, and others in its skilled nursing and senior living network.